
[Federal Register: March 23, 2010 (Volume 75, Number 55)]
[Notices]               
[Page 13766]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr23mr10-68]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2010-N-0001]

 
Food and Drug Administration and Process Analytical Technology 
for Pharma Manufacturing: Food and Drug Administration--Partnering With 
Industry; Public Conference

AGENCY:  Food and Drug Administration, HHS.

ACTION:  Notice of public conference.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA) is announcing a joint 
conference with the University of Rhode Island (URI) College of 
Pharmacy entitled ``FDA and PAT for Pharma Manufacturing: FDA--
Partnering with Industry.'' This 2-day public conference is cosponsored 
by FDA and the URI College of Pharmacy. This public conference is 
intended to disseminate current and accurate information on process 
analytical technology (PAT) to the pharmaceutical industry and create a 
venue for dialogue between PAT users and FDA. The public conference 
will feature FDA's perspective on where PAT will be applicable in the 
manufacturing process and FDA's current thinking on how PAT will be 
reviewed in new and abbreviated new drug applications, amendments, or 
supplements to an application.
    Date and time: The public conference will be held on May 11 and 12, 
2010, from 8 a.m. to 5 p.m.
    Location: The public conference will be held at the Hyatt Regency 
Bethesda, One Bethesda Metro, Bethesda, MD 20814, 301-657-1234.
    Contact Persons:
    For information regarding the conference and registration: Christi 
Counts, Pharma Conference Inc., P.O. Box 291386, Kerrville, TX, 78029-
1386, 830-896-0027, FAX: 830-896-0029, http://www.pharmaconference.com.
    For information regarding this notice: Chris Watts, Center for Drug 
Evaluation and Research, Food and Drug Administration, 10903 New 
Hampshire Ave., Bldg. 51, rm. 4142, Silver Spring, MD 20993-0002, 301-
796-1625.
    Registration: There is a registration fee. The registration fee 
includes conference materials, continental breakfast, breaks, and 
lunches. For payment received by April 15, 2010, the fee is $1,795. For 
payment received after April 15, 2010, the fee is $1,995. The fee for 
government employees is $750. The following forms of payment will be 
accepted: American Express, Visa, Mastercard, and company checks. No 
checks will be accepted on site. Early registration is recommended 
because seating is limited. There will be no onsite registration. To 
register for the public conference online, please visit http://
www.pharmaconference.com/upcoming2010/beth_10.htm. To register by 
mail, please send your name, title, firm name, address, telephone and 
fax numbers, e-mail, and credit card information or a company check for 
the fee to Pharma Conference Inc., P.O. Box 291386, Kerrville, TX, 
78029-1386. To register by overnight mail, the address is Pharma 
Conference Inc., 819 Water St., suite 350, Kerrville, TX, 78028.
    If you need special accommodations due to a disability, please 
notify Pharma Conference Inc., once you receive your registration 
confirmation so these needs can be passed on to the conference venue.

    Dated: March 17, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010-6265 Filed 3-22-10; 8:45 am]
BILLING CODE 4160-01-S

